A single human gene, SIAT1, encodes the /3-galactoside a2,6-sialyltransferase from which multiple mRNA isoforms are generated. In rat, expression of the hepatic mRNA isoform (Form 1) has been defined with respect to the transcriptional initiation site and promoter region. We show here that a similar hepatic SIAT1 mRNA isoform exists in human. Another human mRNA isoform, a mature B-cell-specific mRNA isoform (Form 2), was previously reported. Here, we used 5'-RACE and SI nuclease protection analysis to define the 5'-untranslated region of Form 2 human SIAT1 mRNA. We demonstrate conclusively that 
Introduction
The /3-galactoside a2,6-sialyltransferase (SIAT1 (EC2.4.99.1)) mediates the attachment of sialic acid to galactose in SA(o2,6)Gal()31/4)GlcNAc-R, an oligosaccharide structure common on cell surface and secreted mammalian glycoproteins and glycolipids. Although SIAT1 and its cognate sialyl linkage are present in most tissues and cells, the level of expression among different cell types is often dramatically different. Functional specialization of the a2,6-sialyl linkage in different tissues has been implicated as well. Among serum glycoproteins where the a2,6-sialyl linkage is the predominant form of sialic acid modification, it contributes to the longevity of these serum components in systemic circulation (Steer and Ashwell, 1980) . In liver, the principal biosynthetic site of serum glycoproteins, SIAT1 is expressed to high levels and is transcriptionally regulated by glucocorticoids (Wang et al, 1990b) . In mature B-lymphocytes, cell-surface a2,6-sialyl structures serve as recognition ligands to the adhesion molecules CD220 on B-cells and CD45 on T-cells (Stamenkovic et al, 1991; Aruffo et al, 1992) . B-CelJ maturation is accompanied by a dramatic induction of SIAT1 expression and consequent display of cell-surface «2,6-sialyl linkage (Wang etai, 1993) . Aberrant a2,6-sialylation is also closely correlated with the tumorigenicity of colorectal carcinoma (Dall'Olio et al, 1992) as well as susceptibility to killing by NK cells (Bezouska et al, 1994) . a2,6-Sialyl modification may also serve a masking function by depleting the Gal()31/4)GlcNAc-precursor needed for the elaboration of other biologically significant glycan structures (Grollman et al, 1992; Nemansky and Van den Eijnden, 1992; Grollman et al, 1993) .
A complex network of regulatory pathways is implicated by the apparent functional heterogeneity and tissue differences in SIAT1 expression. In human, the single SIAT1 gene is located on chromosome 3 (q21-28) (Wang et al, 1993) . Multiple SIAT1 mRNA forms, differing only in the 5'-untranslated region, have been described in both human and rat. In rat, a hepatic/small intestine-specific mRNA isoform has been extensively studied (Svensson etal, 1990; Vertino-Bell et al, 1994) . In rat liver, SI ATI expression is modulated by glucocorticoids (Wang et al, 1990b) . Recently, a similar hepatic-specific mRNA isoform has been shown to exist in human (Aas-Eng, 1995) . Two additional SIAT1 mRNA forms have been documented in human cells. One isoform that appears to be restricted to mature B-cells is thought to be responsible for the elaboration of the sialyl ligand for CD22/3 and CD45. Another SIAT1 isoform was initially characterized in placenta (Grundmann etal, 1990) , but its expression in B-lymphocytes has also been documented (Wang et al, 1993) . The apparent lack of sequence similarity in the 5'-untranslated region among the known SIAT1 mRNA isoforms has led to the hypothesis that multiple promoter regions and multiple transcription initiation sites result in the generation of the mRNA isoforms.
Here we provide conclusive evidence that the B-cellspecific SIAT1 mRNA isoform is transcriptionally initiated from a site distinct and separate from the initiation site of the human hepatic SIAT1 mRNA isoform. We characterized the genomic sequences that encompass the distinct and separate promoter regions. Residing immediately upstream of the B-cell-specific SIAT1 transcription site are cis-elements with consensus to AP-1, AP-2, NF-KB, NF-IL-6, C/EBP, and CREB. We demonstrate efficient expression of a reporter gene under the control of the respective SIAT-1 promoters. Reporter gene expression in Louckes cells, a B-lymphoblastoid cell line, is optimal when regu- lated by the B-cell S1AT1 promoter. In contrast, reporter expression in HepG2, a cell line of hepatic origin, is optimal when under the control of the putatively hepatic SIAT1 promoter. Figure 1 is a schematic diagram of human SIAT1 gene and the three known forms of SIAT1 mRNA that differ only in the structure of the 5'-untranslated region (Grundmann et al., 1990; Stamenkovic et al, 1990; Aasheim et al, 1993; Aas-Eng et al, 1995) . Experimentally, these mRNA isoforms can be distinguished from each other by the presence or absence of sequence contributions from Exon X or Exon Y + Z. SIAT1 is subjected to different programs of expression in different tissues. This is illustrated in Figure 2. Northern blots of mRNA from various human tissues and cells were hybridized with a probe recognizing the coding region that is common to all SIAT1 mRNA isoforms ( Figure 2A ). Among the tissues examined, SIAT1 mRNA levels are highest in liver. SIAT1 mRNA is also abundant in spleen, thymus, and prostate, with lesser levels in heart, kidney, ovary, small intestine, colon, and peripheral blood leukocytes. Brain, placenta, lung, pancreas, skeletal muscle, and testis express lowest levels of SIAT1 mRNA. The blots were also probed for sequences corresponding to Exon X ( Figure 2B ) and to Exon Y + Z ( Figure 2C ) to assess the differential expression of the SIAT1 mRNA isoforms. Using this approach, Form 3 mRNA is detected by presence of Exon Y + Z; Form 2 mRNA is detected by the presence of Exon X; Form 1 mRNA by the absence of Exons Y, Z, and X. It is clear that liver expresses predominantly the Form 1 mRNA that lacks sequences from either Exons Y, Z, or X. Form I is also the predominant SIAT1 mRNA isoform in HepG2, a human hepatoma cell line. With the exception of liver, tissue differences in the signal for Exon Y + Z closely parallel those observed when the coding region was probed (compare Figure 2C with Figure 2A ). This is suggestive that Form 3 comprises a comparatively constant percentage of SIAT1 expression in most tissues. Another SI ATI isoform, Form 2, contains Exon X but not Exon Y + Z (see Figure  1 ). Our lab has previously documented the expression of Form 2 SIAT1 mRNA in mature B-lymphoblastoid cells (Wang et al., 1993) . As shown in Figure 2B , Louckes and Jok-1 cells, both lymphoblastoid lines representing the mature stage of B-cell differentiation, express Form 2 SIAT1 mRNA. Among tissues examined, Form 2 mRNA was detected only in kidney and spleen.
Results

Assessment of tissue-specific expression of SI AT] mRNA isoforms
Transcription initiation region of Form 2 SI A Tl mRNA
The synthetic oligonucleotide HST-p5 that is complementary to a region within Exon I was used to prime reverse transcription of Louckes RNA. Subsequent PCR amplification (see Materials and methods) resulted in the amplification of a 331 bp product ( Figure 3A ) that putatively contained the extreme 5' end of SIAT1 mRNA expressed in Louckes. Positive hybridization of the blotted PCR product by a probe for Exon X indicates that the 331 bp product is derived from Form 2 mRNA (data not shown). The PCR product was cloned, and eight clones were chosen for sequence analysis (see Materials and methods). Previously published data on the Form 2 SIAT1 mRNA contains sequence information only up to nucleotide +27 as shown in Figure 3C (Bast et al., 1992) . All eight clones contain an additional 26 bp of 5' sequences, up to nucleotide + 1 as depicted in Figure 3C . Sequence comparison with the previously isolated (Wang et ai, 1993) Exon X genomic region confirmed complete colinearity of the additional 5' cDNA sequence with genomic Exon X. This observation strongly suggests ' end-labeled probe that is complementary to Exon X and 5' flanking sequence was generated. Total RNA from Louckes (lane 1) or E.coh RNA (lane 2) was solution-hybridized to the probe, subjected to SI nuclease digestion and analyzed in a denaturing 8% acrylamide gel. Lane 3 is radioactively labeled Hpa II fragment of BlueScript as molecular size standard. C, Nucleotide sequence of 5'-flanking sequence adjacent to Exon X (see Materials and methods). Nucleotide position #1 is the predicted transcription initiation site of P2. Potential regulatory elements are identified using SIGNAL SCAN program (Prestridge, 1991) , underlined and illustrated above the sequence This sequence has been deposited into GenBank with accession number U27570.
transcnptional initiation of Form 2 mRNA at position + 1. To demonstrate conclusively transcription initiation at position + 1, a single-stranded, end-labeled probe complementary to Exon X and adjacent 5' region was generated and used for SI nuclease protection analysis of Louckes mRNA. The result of this analysis is shown in Figure 3B . A major SI nuclease protected signal of 75 nt is evident in the presence of Louckes RNA (lane 1) but not in a parallel reaction containing only control E. coli RNA (lane 2). The predicted size of this nuclease-protected signal is fully consistent with the transcnptional initiation at position + 1. Figure 3C also summarizes sequence 5' of the initiation site that putatively encompasses the transcription promoter region for Form 2 SIAT1 mRNA. This putative promoter region, P2, contains a number of consensus to known ds-acting regulatory elements. Among these elements are one API binding site at position "768; five AP2 sites at positions "641, "456, "397, "357, "66; two NF-KB at "703 and "296; three C/EBP at "546, "230, and "77; two 2), and pCAT-p2(1.6) (lanes 1-6, respectively). This experiment was performed twice, each in duplicates, with identical results. Shown is the result from one of the two duplicates from one of the two experiments.
NF-IL6 at "546, and "62; one CREB at "47 (Prestridge, 1991) . Finally, a consensus TATA box is located between 20 and 30 bases 5' of the predicted transcriptional start site.
Transcriptional regulatory function of P2 region
Chimeric constructs, containing progressive 5' truncations of the P2 promoter region of SIAT1 fused to the CAT structural gene ( Figure 4A ), were tested by transfection into Louckes, a cell line that normally expresses Form 2 SIAT1 mRNA. The result of this experiment is shown in Figure 4B . Not unexpectedly, minimal CAT expression was observed in cells transiently transfected with pCATenhancer(null), the parental plasmid lacking transcriptional promoter sequences (lane 2). Surprisingly, also minimal CAT expression was observed when pCAT-control, a plasmid containing the SV40 transcriptional regulatory sequences (lane 1) was tested. Four constructs were tested in which progressively shorter segments of the SIAT1 P2 region were fused upstream to the CAT structural gene in pCAT-enhancer(null). Maximal CAT expression resulted upon transfection of pCAT-.P2(1.2), containing 1.2 kb of P2 sequence, and pCAT-P2(0.9), containing 0.9 kb of P2 sequence ( Figure 4B , lanes 5 and 4, respectively). Lesser CAT expression resulted upon transfection of pCAT-P2Q..6), containing a longer stretch of P2 sequence ( Figure  4B , lane 6), or pCAT-P2(0.2), containing only a very short segment of the P2 region ( Figure 4B, lane 3) . Together, the data demonstrate the ability of the region immediately flanking the Form 2 SIAT1 initiation to serve as transcriptional promoters and that the sequence between "784 and + 125 is sufficient to promote high level CAT expression in Louckes.
Transcription initiation region of Form 1 SI A Tl mRNA
Synthetic oligonucleotide HST-p27 that is complementary to a region within Exon I was used to prime reverse transcription of HepG2 mRNA. Subsequent PCR amplification (see Materials and methods) resulted in a major 152 bp product and a minor 191 bp product that putatively contain the extreme 5' ends of SI ATI mRNA expressed in HepG2 ( Figure 5A ). The PCR products were cloned. Among the 10 clones chosen for sequence analysis, two clones contained sequence information up to "39, four contained sequence up to + 1, the other four up to + 4. Sequence comparison with the previously isolated Exon I genomic region confirms the complete colinearity of the cloned sequence with Exon I, suggesting transcriptional initiation of Form 1 mRNA from site(s) immediately 5' of Exon I. To assess the precise transcriptional initiation site, RNase protection analysis of HepG2 mRNA using a probe generated from genomic region 5' and including Exon I was performed ( Figure 5B ). In the presence of HepG2 RNA (lane 3), two principal RNase protected regions are visible. The corresponding signals are absent in a parallel reaction containing only control yeast tRNA (lane 2). The sizes of the RNase protected signals (denoted by *) predicts two groups of transcription initiation sites (I and II) that are summarized in Figure 5C . The predicted initiation sites I and II are fully consistent with 5'-RACE products of 191 bp and 152 bp. A consensus region to an 'initiator' sequence (Smale and Baltimore, 1989) resides within 20 bp upstream of each of the initiation sites.
Sequence of this genomic region is shown in Figure 5C . Nucleotide position + 1, for convenient purposes, has been labeled at the first transcription start site in group II for Form 1 SI ATI mRNA. The promoter region, PI, residing upstream of the transcription initiation sites, contains consensus to a number of known ds-acting elements. Among these are APRF binding site at position "379, AP2 site at position "249, NF-IL6 at "237, and HNF-1 at "51.
Differential expression of CA T by PI and P2
Chimeras containing CAT under the control of PI and P2 SIAT1 regulatory regions were tested for differences in efficiency when expressed in Louckes or HepG2 cells. pCAT-P2(0.9), containing 0.9 kb of the P2 regulatory region (see Fig 4) , was compared with CAT-PI(0.2), the CAT chimera containing 0.2 kb of the PI regulatory region.
As shown in Figure 6 , CAT is efficiently expressed in Louckes cells from the P2 regulatory sequences but only marginally from the PI sequence. In contrast, reporter expression in HepG2 cells is strong when under the control of the PI region and comparatively weaker when controlled by the P2 region. Chimeras containing PI regions longer than that included in pCAT-.Pi(0.2) were also tested. However, CAT expression in HepG2 was severely depressed in these longer PI constructs (data not shown) 
Discussion
Most tissues and cell types express SIAT1 and synthesize the cognate sialyl a2,6 linkage. SIAT1 expression results in a number of mRNA isoforms, most of these differ only in the 5'-untranslated region. The existence of multiple promoter regions has been suggested to account for the complete absence of sequence commonality in the extreme 5' region of the mRNAs (Grundmann et al, 1990; Stamenkovic et al, 1990; Aasheim et al, 1993; Aas-Eng et al, 1995) . In human, three such mRNA forms have been identified (see Figure 1) . Two of these, Form 1 and Form 2, have a tightly restricted range of tissue specificity of expression. Form 1 mRNA is known to be expressed only in hepatic cells (Wang et al, 1990b; Svensson et al, 1992) and in the small intestinal epithelium of pre-weaning animals (Vertino-Bell et al, 1994) ; Form 2 mRNA is so far known to be expressed only in mature B cells (Wang et al, 1993) . The third form, Form 3, appears to be a constitutively expressed form in most tissues. In this report, we have established that two physically distinct promoter regions regulate the transcription of the Form 1 and Form 2 SIAT1 mRNAs. On this basis, it is likely that a third distinct promoter region is responsible for transcription of the third known SIAT1 mRNA form. Form 1 SIAT1 mRNA has been extensively characterized in the rat (Wang et al, 1989 (Wang et al, , 1990 Svensson et al, 1992) . In the differential Northern blot analysis ( Figure  2) , we have demonstrated a similar restriction of Form 1 expression to hepatic cells. Here, we used the parallel approach of RNase protection and 5'-RACE analysis to define the transcription initiation sites of Form 1 mRNA at the 5' junction of Exon 1. A heterogenous but closely spaced pattern of transcription starts was noted by both 5'-RACE and RNase protection assays (see Figure 5) . A similar undertaking was reported by Aas-Eng et al. (AasEng et al., 1995) . Our data are in essential agreement except for the notable exception that the heterogenous initiation sites were not reported by Aas-Eng etal Form 1 promoter, PI, residing immediately 5' of Exon I contains a number of consensus to cts-elements also noted in the rat PI region. These include HNF-1 and NF-IL6, a human homolog of murine DBP (Courtois et al, 1988; Ramji et al, 1991) . HNF-1 and DBP are liver-enriched factors that are believed to participate in the hepatic specificity of Form 1 SIAT1 mRNA expression (Svensson et al, 1992) . As in the rat promoter, human PI lacks the canonical TATA box. A GC box, a binding site for the transcription factor Spl that is present in many 'housekeeping' genes lacking TATA boxes, is also notably absent (Reynolds et al, 1984) . Nevertheless, PI did have two 'initiator' sequence regions (YYCAYYYY) which is required for initiation in some TATA-less genes (Smale and Baltimore, 1989) . These regions reside immediately upstream of the two PI initiation points (see Figure 5C ).
Expression of Form 2 SIAT1 mRNA is largely restricted to mature B lymphocytes (Wang et al, 1993) . In Northern blot survey of a number of human tissues (Figure 2) , kidney is the only tissue besides spleen in which Form 2 SIAT1 mRNA was detected. 5'-RACE and SI nuclease protection analysis established the transcription initiation of Form 2 mRNA to the 5' end of Exon X (see Figure 3) . Form 2 promoter, P2, resides immediately 5' of Exon X and contains a canonical TATA box. A number of regions with consensus to transcription factor binding sites are also noted (Prestridge, 1991) , including API (Wasylyk et al, 1989) , AP2 (Imagawa et al, 1987; Mitchell et al, 1987; Faisst and Meyer, 1992) , Spl (Janson et al, 1987) , NF-KB (Hoyos et al, 1989; Lenardo and Baltimore, 1989) , NF-IL6 (Faisst and Meyer, 1992) , CREB (Jameson et al., 1988) , and C/EBP (Johnson, 1987; Costa et al, 1988) . Among these, the presence of two consensus regions for NF-KB binding is most noteworthy. The reported presence of NF-KB binding activity in nuclear extracts of mature B cells but not in pre-B cell lines (Sen and Baltimore, 1986 ) coincides with SIAT1 induction and the appearance of Form 2 mRNA during B cell maturation (Wang et al, 1993) .
PI and P2, when fused upstream to the CAT reporter gene, efficiently regulate CAT expression in transiently transfected cells. In Louckes cells that normally express Form 2 mRNA, maximal efficiency in CAT expression was achieved in constructs containing 1.2 kb and 0.9 kb of P2 sequence. Another construct, containing 1.6 kb of P2, expressed CAT comparatively inefficiently (see Figure 4) . The reason for this is not clear, although the presence of negative acting elements in the longer P2 construct is a likely possibility. Cellular specificity is apparently retained in CAT expression under the control of SIAT1 regulatory regions. PI regulated constructs are expressed most efficiently in HepG2, a cell line of hepatic origin; P2 regulated constructs are expressed most efficiently in Louckes, a Blymphoblastoid cell line.
Central to the elucidation of mechanisms for tissue and developmental specificities of sialic acid moieties on glycoconjugates is the understanding of their cognate sialyltransferases. Although the /3-galactoside a2,6-sialyltransferase activity is ubiquitously present, available data implicate cellular differences in regulation of SIAT1 expression. In hepatocytes, SIAT1 expression is responsive to glucocorticoids (Wang et al, 1990b) but apparently unaffected by the cAMP pathway (Wang et al, 1989) . SI ATI expression in thyrocytes, in contrast, is negatively modulated by TSH via the cAMP pathway (Grollman et al., 1993) . Transient high level SIAT1 expression in the intestinal epithelium of new born animals (Vertino-Bell et al., 1994) and the induction of SIAT1 during B-lymphocyte maturation (Wang et al., 1993) further suggest independent regulation of SIAT1 in different tissues. The existence of multiple promoter regions is ideally suited for such differential requirements for SIAT1 expression in different cell types.
The existence of multiple promoters for the expression of a single gene is a relatively common phenomenon among procaryotes. An example is thepfs/Zoperon of E.coli under the control of two distinct promoters P0 and PI. These promoters endow two separate regulatory mechanisms, one via the CRP-cAMP, the other through glucose, to pts expression (Ryu and Garges, 1994) . Multiple promoters are unusual, although not without precedent among mammalian genes. A number of different promoters regulate the transcription of the human fibroblast growth factor 1 gene. These promoters respond to different physiologic signals and stimuli that result in the differential production of fibroblast growth factor 1 protein in different cells (Chotani et al., 1995) . Multiple promoters and associated alternate transcription initiation sites have also been reported in the rat rolipram-sensitive cAMP phosphodiesterase gene (Monaco et al., 1994) and the inhibin/activin (/3-subunit gene (Feng et al., 1995) . Among the glycosyltransferases, the (/31,4-galactosyltransferase (Shaper et al., 1988) and the N-acetylglucosaminyltransferase I (Yang et al., 1994) are known to be regulated by multiple promoters. Unlike SIAT1 in which the multiple promoters are physically distinct, galactosyltransferase expression is regulated by separate but overlapping promoter regions (Shaper et al., 1988; Harduin-Lepers et al., 1992; Shaper et al., 1994) .
Among some other glycosyltransferase activities, most notably the al,3-fucosyltransferase activities (Weston et al, 1992) and the a-galactoside a2,3-sialyltransferase activities (Chang et al., 1995) , multiple genes encode enzymes with closely related catalytic specificities but different patterns of tissue expression. While differences in their catalytic specificities have been amply documented, whether one enzyme may adequately substitute for a related enzyme in normal physiologic functions remains to be determined. What remains a possibility, nevertheless, is that these multiple genes evolved via evolutionary forces similar to that which gave rise to the multiple promoters of SIAT1. The need for multiple regulatory pathways may be common among gJycosyltransferases for which expression is ubiquitous, but the degree of expression may need to be differentially modulated in different cell types. In any event, detailed knowledge of the precise functionality and regulation of the individual glycosyltransferases is essential for the overall understanding of the correct expression of biologically significant glycan epitopes.
Materials and methods
Cell culture and northern analysis
The human lymphoblastoid lines Louckes and Jok-1 and the human hepatoma line HepG2 were obtained and maintained as previously described (Wangera/., 1993).Total cellular RNA was prepared from human cell lines mentioned above using the guanidine isothiocyanate method (Chirgwin et al., 1979) . Ten micTograms of each total RNA were separated on formaldehyde agarose gels (Boedtker, 1971) , and electrotransferred onto nylon filter (Zetabind, Cuno Inc., Meriden, CT). Human multiple tissue blots of poly A+ RNAs were purchased from Clontech Laboratories (Palo Alto, CA). Approximately 2.0 /xg of poly A+ RNA were in each lane on the purchased blots. Hybridization procedure and generation of the radiolabeled probes (-1 x 10* c.p.m./ml) specific to human SI ATI coding region, Exon X, and Exon Y + Z were as described previously (Wang et al., 1993) . The blots were exposed to XAR-5 films (Eastman Kodak Co., Rochester, NY) for 1-4 d with an intensifying screen and stripped according to the manufacturer's instruction for rehybridization. Alternatively, the blots were quantitated by Phosphorlmager (Molecular Dynamics, Sunnyvale, CA).
Cloning of the 5' end of the human SI AT! transcripts
Total cellular RNA was isolated from Louckes cells and HepG2 cells and poly A + RNA purified by oligo(dT) cellulose chromatogTaphy (Aviv and Leder, 1972) . First strand cDNAs were synthesized from mRNA derived from 200 /ig of total RNA from Louckes cells (5'-AmpliFINDER RACE Kit, Clontech Lab, Palo Alto, CA) using HST-p5 (Wang et al. 1993) and subsequently ligated with AmpliFlNDER Anchor (5'-P-CAC-GAATTCACTATCGATTCTGGAACCTTCAGAGG-3'NH2) in which an EcoRI restriction site has been included. The anchor-ligated cDNAs were then subjected to PCR amplification as described previously (Wang et al., 1993) . PCR primers used were anchor pnmer (5'-CTGGTTCGGCCCACCTCTGAAGGTTCCAGAATCGATAG-3') and HST-p5. To clone the PCR product, HST-p28 (5'-CTATTATCCAT-GGGAGGGAAGCTTTATTG-3') which contains a mutation to generate a Hindi 11 restriction site was used as a nested primer. PCR product digested with EcoRI and Hindlll was cloned into pBS-SK + /EcoRI/ Hindlll (Stratagene. La Jolla, CA). Clones of interest were screened using the Exon X probe and sequenced using Sequenase (modified T7 polymerase from U. S. Biochemicals, Cleveland, OH) by the dideoxynucleotide chain termination method. For HepG2 cells, first strand cDNAs were synthesized using HST-p27 (5'-CTATTATCCATGG-GAGGGAAGGTTT-3') and ligated with AmpliFlNDER Anchor. The anchor-ligated cDNAs were PCR-amplified using HST-p27 and anchor primer. PCR product was then cloned into plasmid pCRII using TA cloning kit (Invitrogen. San Diego, CA).
SI nuclease protection assay and nbonuclease protection assay
Two plasmids, pBS-PX and pBS-PL which, respectively, contained Exon X and Exon I as well as their respective 5' flanking genomic sequences, were constructed to generate probes for the assays. To construct pBS-PX, a 234 bp fragment was PCR-amplified from AHG4 (Wang et al., 1993) using HST-P40 (5'-ACTCCAACCTGGTCGACAGAGC-3') and HST-P41 (5'-TGGGAGAAGGGATCCAGAGCTT-3'), digested with BamHI and Sail. The 209 bp digested fragment was cloned into pBS-KS+/BamHI/SalI. For pBS-PL, a 277 bp fragment was PCR amplified from previously isolated AHG9 (Wang el al, 1993) using HST-P28 and HST-P39 (5'-TGTGCTGTTCACGGATCCAGAGC-3'), and digested with BamHI and Hindlll, and cloned into pBS-SK + /BamHI/HindIII. The integrity of both clones was sequence-verified. SI nuclease assay was performed using SI Assay Kit (Ambion Inc., Austin, TX). Briefly, pBS-PX was digested with BamHI followed by dephosphorylation using alkaline phosphatase (Boehringer Mannhein, Indianapolis, IN) and subsequent digestion with Sail to generate a 209 bp fragment. Two picomoles of the fragment were 5'-end labeled with y^P-ATP (3000 Ci/mmol, Amersham, Arlington Heights, IL). Probe (4 x 10 4 c.p.m.) was added to 50 tig of either E.coli RNA or Louckes total RNA and ethanol coprecipitated. The pellet was resuspended in 10 y\ of hybridization solution (80% deionized formamide, 100 mM sodium citrate, pH 6.4, 300 mM sodium acetate, pH 6.4,1 mM EDTA), denatured at 90°C for 3 min, cooled down slowly to 42°C, and then allowed to hybridize at 42°C overnight. Following hybridization, 50 U of SI nuclease were added and samples were incubated at 25°C for 30 min. After incubation, 40 /xl of SI nuclease inactivation buffer were added, and the samples were ethanol-precipitated. The pellets were resuspended in TE and sequencing loading dye and then analyzed on a denaturing 8% polyacrylamide gel.
For the RNase protection assay, 0.5 fig of BamHI-linearized pBS-PL was used to synthesize RNA probe using T7 RNA polymerase (Promega, Madison, WI) and o^P-CTP (800 Ci/mmol, NEN, Boston, MA). Labeled RNA probe (1 x 10 5 c.p.m.) was then added to 10 /xg of HepG2 total RNA or yeast tRNA and the mixtures precipitated with ethanol. The Guardian RNase Protection Assay Kit (Clontech Laboratories, Palo Alto, CA) was used for the RNase protection assays.
Construction of plasmids for transient cell transaction and transient transfection analysis
A plasmid, pSK-HGX4Ps containing 4.6 kb flanking sequence of Exon X, was constructed by subcloning of the genomic clone AHG4 (Wang et aL, 1993) into Bluescript. Serially 5'-truncated constructs of pSK-HGX4Ps were obtained by Exo III and Mungbean nuclease digestion. Clones were sequence-analyzed to determine the precise degree of 5' deletion. Inserts were placed upstream of the CAT coding region in pCAT-enhancer (see schematic in Figure 4 ). An additional construct, pCAT-P2(0.2), was obtained by inserting the 160 bp Hind III/Pst I restriction fragment into pCAT-enhancer.
For CAT constructs, another clone, pHG9N2 (Wang et ai, 1993) , containing 5' genomic sequence flanking Exon I was used as starting material. A fragment released by Pst I digest that contains the 70 bp Exon I and 1 kb of 5'-flanking sequence was placed upstream of the CAT structural gene to obtain pCAT-/7(1.0). The second construct pCAT-.P7(0.2) contains 70 bp of Exon I and 162 bp of the adjacent flanking region.
Transient transfection of HepG2 cells was performed using the calcium phosphate transfection technique (Ausubel et ai, 1989) . Equal molanty of plasmid DNA was prepared in 0.5 ml of 0.25 M CaCl 2 at -10 #ig/ml. The DNA solution was added to 0.5 ml of 2 x HBS buffer (280 mM NaCl, 10 mM KC1, 3 mM NaHPO 4 , 12 mM dextrose, 50 mM HEPES, pH 7.5) and allowed to precipitate at room temperature for 20 min. The precipitate was added to cells grown in 100 mm plastic dishes (40% confluent) and incubated for 5 h. Cells were washed two times with phosphate-buffered saline (PBS) and allowed to recover in complete media for 24-48 h before assaying for CAT activity. Transient transfection of Louckes cells was performed using electroporation (GIBCO, BRL). Cells (5 X 10" were resuspended in 0.6 ml of RPMI 1640 + 10% FBS containing equal molarity of plasmid DNA (-25 fj.g) and electroporated in 0.4 cm cuvette at room temperature under 250 V, low R, and 1180 fiF. Cells were cultured in 10 ml of complete medium for 24-48 h before assaying for CAT activity. CAT assay was performed according to Ausubel et at. with some modifications. In brief, transfected cells were washed twice with PBS and once with TEN (40 mM Tns-Cl, pH 7.5,1 mM EDTA, pH 8.0, 150 mM NaCl) and resuspended in 100 jtl of 0.25 M Tris-Cl, pH 8.0. Cells were sonicated briefly, incubated at 65°C for 5 min, frozen and thawed once, and clarified by quick centrifugation. Protein concentration in each cellular extract was normalized by the Bradford reagent (BioRad, Richmond, CA). Twenty microliters of cell extracts was used for each measurement for CAT activity. CAT activity was quantitated by thin layer chromatography
